These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 22288139)

  • 1. [Iopamidol is a safe choice in the practice of diagnostic imaging].
    Filatov DN; Cherkavskaia OV; Korobkova IZ
    Vestn Rentgenol Radiol; 2011; (3):69-72. PubMed ID: 22288139
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous contrast medium-induced nephrotoxicity: is the medical risk really as great as we have come to believe?
    Katzberg RW; Newhouse JH
    Radiology; 2010 Jul; 256(1):21-8. PubMed ID: 20574082
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute renal failure from contrast medium: ... and remember simple and cheap measures.
    Patel A
    BMJ; 2006 Sep; 333(7569):653-4. PubMed ID: 16990331
    [No Abstract]   [Full Text] [Related]  

  • 4. Renalguard system: a dedicated device to prevent contrast-induced acute kidney injury.
    Briguori C
    Int J Cardiol; 2013 Sep; 168(2):643-4. PubMed ID: 22236513
    [No Abstract]   [Full Text] [Related]  

  • 5. Urography into the 21st century: new contrast media, renal handling, imaging characteristics, and nephrotoxicity.
    Katzberg RW
    Radiology; 1997 Aug; 204(2):297-312. PubMed ID: 9240511
    [No Abstract]   [Full Text] [Related]  

  • 6. Contrast-induced nephropathy: review of incidence and pathophysiology.
    Quader MA; Sawmiller C; Sumpio BA
    Ann Vasc Surg; 1998 Nov; 12(6):612-20. PubMed ID: 9841696
    [No Abstract]   [Full Text] [Related]  

  • 7. Contrast-induced kidney injury: mechanisms, risk factors, and prevention.
    Seeliger E; Sendeski M; Rihal CS; Persson PB
    Eur Heart J; 2012 Aug; 33(16):2007-15. PubMed ID: 22267241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detecting a peak in fraction beta by capillary electrophoresis: interference due to iomeprol].
    Wils J; Lavoinne A; Vaillant C
    Ann Biol Clin (Paris); 2013; 71(2):196-8. PubMed ID: 23587586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging the pH evolution of an acute kidney injury model by means of iopamidol, a MRI-CEST pH-responsive contrast agent.
    Longo DL; Busato A; Lanzardo S; Antico F; Aime S
    Magn Reson Med; 2013 Sep; 70(3):859-64. PubMed ID: 23059893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iodinated contrast media and the role of renal replacement therapy.
    Weisbord SD; Palevsky PM
    Adv Chronic Kidney Dis; 2011 May; 18(3):199-206. PubMed ID: 21531326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of low-osmolality contrast media on red cell filterability.
    Imai H; Hiruma H; Kumazaki T; Uyesaka N
    Acta Radiol; 1993 May; 34(3):214-9. PubMed ID: 8489832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal replacement therapy for prevention of contrast-induced acute kidney injury: a meta-analysis of randomized controlled trials.
    Song K; Jiang S; Shi Y; Shen H; Shi X; Jing D
    Am J Nephrol; 2010; 32(5):497-504. PubMed ID: 20975263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury.
    Briguori C; Visconti G; Focaccio A; Airoldi F; Valgimigli M; Sangiorgi GM; Golia B; Ricciardelli B; Condorelli G;
    Circulation; 2011 Sep; 124(11):1260-9. PubMed ID: 21844075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iopamidol as a responsive MRI-chemical exchange saturation transfer contrast agent for pH mapping of kidneys: In vivo studies in mice at 7 T.
    Longo DL; Dastrù W; Digilio G; Keupp J; Langereis S; Lanzardo S; Prestigio S; Steinbach O; Terreno E; Uggeri F; Aime S
    Magn Reson Med; 2011 Jan; 65(1):202-11. PubMed ID: 20949634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephrotoxicity of high and low osmolar contrast media: case control studies following digital subtraction angiography in potential risk patients.
    Scherberich JE; Fischer A; Rautschka E; Kollath J; Riemann H
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():91-4. PubMed ID: 2568816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evaluation of contrast-related renal failure.
    Bettmann MA
    AJR Am J Roentgenol; 1991 Jul; 157(1):66-8. PubMed ID: 2048541
    [No Abstract]   [Full Text] [Related]  

  • 17. Contrast medium use.
    Davidson C; Stacul F; McCullough PA; Tumlin J; Adam A; Lameire N; Becker CR;
    Am J Cardiol; 2006 Sep; 98(6A):42K-58K. PubMed ID: 16949380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT).
    ACT Investigators
    Circulation; 2011 Sep; 124(11):1250-9. PubMed ID: 21859972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-Associated Acute Kidney Injury.
    Mehran R; Dangas GD; Weisbord SD
    N Engl J Med; 2019 May; 380(22):2146-2155. PubMed ID: 31141635
    [No Abstract]   [Full Text] [Related]  

  • 20. Contrast-induced nephropathy after a second contrast exposure.
    Trivedi H; Foley WD
    Ren Fail; 2010; 32(7):796-801. PubMed ID: 20662692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.